4048 Second alpha-helical domain in heme-dependent catalases
Ligands and drugs
Aggregated over all current member domains of this group. Drug annotations come from DrugDomain; buffers and crystallization additives are excluded from the tables below.
Chemical profile
ClassyFire chemical superclasses of the ligands bound by this X-group's proteins, from DrugDomain annotations.
The raw number of superclasses rises with the number of proteins sampled; the per-20 value compares X-groups at equal depth.
| Superclass | Proteins | Expected | 0.25×observed / expected4× | Ratio | Significance |
|---|---|---|---|---|---|
| Nucleosides, nucleotides, and analogues | 10 | 5.5 | 1.83× | q = 0.06 | |
| Homogeneous metal compounds | 5 | 9.7 | 0.52× | q = 0.07 | |
| Homogeneous non-metal compounds | 3 | 4.2 | 0.71× | not tested | |
| Benzenoids | 1 | 1.4 | 0.69× | not tested | |
| Organoheterocyclic compounds | 2 | 3.0 | 0.66× | not tested | |
| Organic acids and derivatives | 2 | 3.1 | 0.66× | not tested | |
| Organic oxygen compounds | 2 | 3.9 | 0.51× | not tested |
Unit: a protein (UniProt accession) with a ligand-binding domain in this X-group, counted once per superclass. Expected counts use each superclass's frequency across all ligand-binding X-groups; significance is Fisher's exact test with Benjamini–Hochberg correction. Buffers and crystallization additives are excluded. ECOD v295.2; the method follows the ECOD 2027 update, whose published figures used a slightly different artifact filter.
DrugBank compounds
| DrugBank | PDB ligand | Name | Domains |
|---|---|---|---|
| DB02338 | NDP | NADPH | 84 |
| DB00141 | NAG | N-Acetylglucosamine | 4 |
| DB02232 | CAQ | 1,2-Dihydroxybenzene | 4 |
| DB03110 | 2CH | 2-Chlorophenol | 4 |
| DB09526 | HQE | Hydroquinone | 4 |
| DB11085 | RCO | Resorcinol | 4 |
| DB11091 | PEO | Hydrogen peroxide | 4 |
| DB11359 | JZ3 | Guaiacol | 4 |
| DB00160 | ALA | Alanine | 2 |
| DB01213 | — | Fomepizole | 1 |
| DB01694 | TAR | D-tartaric acid | 1 |
| DB03461 | NAP | Nicotinamide adenine dinucleotide phosphate | 1 |
| DB09061 | — | Cannabidiol | 1 |
| DB09096 | — | — | 1 |
| DB14011 | — | — | 1 |
| DB14556 | F50 | Peracetic acid | 1 |
Most frequently bound compounds
| PDB ligand | Name | Domains in contact |
|---|---|---|
| NDP | NADPH DIHYDRO-NICOTINAMIDE-ADENINE-DINUCLEOTIDE PHOSPHATE | 110 |
| CAmetal | CALCIUM ION | 35 |
| NAG | 2-acetamido-2-deoxy-beta-D-glucopyranose | 9 |
| 3TR | 3-AMINO-1,2,4-TRIAZOLE | 8 |
| LLR | (~{S})-azanyl-[2-[[3-bromanyl-4-(diethylamino)phenyl]methyl]hydrazinyl]methanethiol | 4 |
| PEO | HYDROGEN PEROXIDE | 4 |
| CAQ | CATECHOL | 3 |
| CL | CHLORIDE ION | 3 |
| HQE | benzene-1,4-diol | 3 |
| 2CH | 2-CHLOROPHENOL | 2 |
| F50 | ETHANEPEROXOIC ACID | 2 |
| JZ3 | Guaiacol | 2 |
| AE3 | 2-(2-ETHOXYETHOXY)ETHANOL | 1 |
| NAP | NADP NICOTINAMIDE-ADENINE-DINUCLEOTIDE PHOSPHATE | 1 |
| TAR | D(-)-TARTARIC ACID | 1 |